Prot #NC-6004-004A: A Phase 1b/2 Dose Escalation and Expansion Trial of NC-6004 (Nanoparticle Cisplatin) plus Gemcitabine in Patients with Advanced Solid Tumors or Squamous Non-Small Cell Lung, Biliary Tract, and Bladder Cancer

Project: Research project

Project Details

StatusFinished
Effective start/end date8/29/17 → 8/29/20

Funding

  • PPD Investigator Services, LLC (Prot #NC-6004-004A // Prot #NC-6004-004A)
  • NanoCarrier Co., Ltd. (Prot #NC-6004-004A // Prot #NC-6004-004A)